CHARACTERIZATION OF METHADONE RECEPTOR SUBTYPES PRESENT IN HUMAN BRAIN AND LUNG TISSUES

Citation
R. Maneckjee et Jd. Minna, CHARACTERIZATION OF METHADONE RECEPTOR SUBTYPES PRESENT IN HUMAN BRAIN AND LUNG TISSUES, Life sciences, 61(22), 1997, pp. 333-338
Citations number
18
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Journal title
ISSN journal
00243205
Volume
61
Issue
22
Year of publication
1997
Pages
333 - 338
Database
ISI
SICI code
0024-3205(1997)61:22<333:COMRSP>2.0.ZU;2-X
Abstract
In addition to their use in pain control, opioids can function as regu lators of tumor cell growth. We have found that the therapeutic opioid , methadone, significantly inhibits the in vitro and in vivo growth of human lung cancer cells, and this effect appears to be mediated by sp ecific, high affinity, non-conventional opioid binding sites. The pres ent study indicates the existence of multiple subtypes of binding site s mediating the peripheral and central nervous system actions of this drug. Pharmacological and biochemical characterizations of the methado ne binding sites expressed in human brain and normal lung tissues indi cate that these sites are distinct from each other and from other opio id receptor types present on human and rat brain membranes, as well as those expressed in human lung cancer cells. The identification of dis tinct methadone receptor types in the different tissues could lead to the development of more selective and less toxic drugs targeted toward the tumor cells. (C) 1997 Elsevier Science Inc.